Another force seeking to move the needle on an open access approach to sharing trial data is the NGO advocacy community. The leading player currently is Bioethics International, a 501(c)(3) non-profit group founded in 2005 and based in New York, with major funding from the Laura and John Arnold Foundation – which also supports the work of the Boston-based drug pricing watchdog, the Institute for Clinical and Economic Review (ICER). Its Board of Directors and Advisors includes representatives from the Bill & Melinda Gates Foundation, Barclay’s Capital, the International AIDS Vaccine Initiative and former top officials from the FDA.
Bioethics International’s mission is to measure and benchmark the clinical trial transparency of new drugs, drug companies and trial sponsors,...
